Nuvation Bio Inc. Class A Common Stock vs NXP Semiconductors N.V. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B), while NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 33.5× Nuvation Bio Inc. Class A Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.
| NUVB | NXPI | |
|---|---|---|
Market Cap | $1.74B | $58.27B |
Volume | 9,289,619 | 3,950,702 |
Sector | Health | Technology |
52-Week High | $9.54 | $332.67 |
52-Week Low | $3.41 | $184.19 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $1.33B | $66.38B |
Dividend Yield | — | 1.76% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →